Legend Biotech
first in human phase dose finding study in legend | Legend Biotech
Company
Deck Type
IPO
Sector
Industry
Deck date
May 2020
Slide
13 of 42
Related slides by other companies
MindMed
Investor Presentation
December 2024
phase trial schematic schematic week a dose optimization study of | MindMed
Larimar Therapeutics
Investor Presentation
October 2022
upcoming phase four week dose exploration study | Larimar Therapeutics
MindMed
Investor Presentation
December 2024
for gad phase study designs | MindMed
MindMed
Investor Presentation
November 2024
phase trial schematic emerge study study week gee toe a study single dose of for | MindMed
Other recent decks by Legend Biotech
See all presentations (6 decks)
Investor Presentation
April 2025
Results
November 2024
Investor Presentation
January 2024
Results
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights